Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Synthomer plc (LON:SYNT - Get Rating) has received a consensus recommendation of "Hold" from the seven analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is GBX 514 ($6.31).
Several analysts recently issued reports on SYNT shares. Barclays downgraded Synthomer to an "equal weight" rating and cut their price target for the stock from GBX 420 ($5.15) to GBX 323 ($3.96) in a report on Thursday, June 16th. Canaccord Genuity Group cut their price target on Synthomer from GBX 750 ($9.20) to GBX 575 ($7.05) and set a "buy" rating on the stock in a report on Thursday, March 10th. Finally, Berenberg Bank reissued a "hold" rating and issued a GBX 350 ($4.29) price target on shares of Synthomer in a report on Wednesday, March 23rd.
In other news, insider Steve Bennett purchased 6,314 shares of the stock in a transaction dated Monday, April 4th. The shares were bought at an average cost of GBX 309 ($3.79) per share, for a total transaction of £19,510.26 ($23,936.03). Also, insider Holly Van Deursen purchased 9,000 shares of the stock in a transaction dated Tuesday, May 3rd. The shares were purchased at an average price of GBX 308 ($3.78) per share, for a total transaction of £27,720 ($34,008.10).
Shares of LON SYNT opened at GBX 233.80 ($2.87) on Thursday. The company has a market cap of £1.09 billion and a price-to-earnings ratio of 487.08. Synthomer has a 12-month low of GBX 232.20 ($2.85) and a 12-month high of GBX 570.50 ($7.00). The company has a current ratio of 1.91, a quick ratio of 1.43 and a debt-to-equity ratio of 64.18. The stock's 50 day simple moving average is GBX 288.69 and its 200 day simple moving average is GBX 319.26.
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you! His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.
Further ReadingIt’s Time To Rotate Out Of McCormick & CompanyConn’s Stock is Getting CheapLet General Mills Command A Position In Your Defensive PortfolioDon’t Bet On A Rebound In Unifirst, Yet Should Nike (NYSE: NKE) Be In Your Portfolio For The Rest Of 2022?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Today Kate sits down with repeat guest Andrew Chanin, Co-Founder and CEO of ETF manager ProcureAM. Andrew shares the story behind the launch of the Procure Disaster Recovery Strategy ETF (FEMA).
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.